Mesna
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
347 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lymphoma | D008223 | — | C85.9 | 26 | 59 | 5 | 2 | 6 | 85 |
| Multiple myeloma | D009101 | — | C90.0 | 8 | 12 | 2 | 1 | — | 19 |
| Germ cell and embryonal neoplasms | D009373 | — | — | 3 | 6 | 1 | 1 | 3 | 12 |
| Plasma cell neoplasms | D054219 | — | — | 3 | 7 | 2 | 1 | — | 11 |
| Sclerosis | D012598 | — | — | 4 | 4 | 4 | 1 | — | 11 |
| T-cell lymphoma | D016399 | — | — | 1 | 7 | — | 2 | — | 9 |
| Systemic scleroderma | D012595 | EFO_0000717 | M34 | 3 | 3 | 3 | 1 | — | 8 |
| Diffuse scleroderma | D045743 | EFO_0000404 | — | 3 | 3 | 3 | 1 | — | 8 |
| T-cell lymphoma peripheral | D016411 | — | — | 1 | 5 | — | 2 | — | 7 |
| Medulloblastoma | D008527 | — | — | 1 | 2 | 2 | 1 | 1 | 7 |
Show 4 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Leukemia | D007938 | — | C95 | 29 | 48 | 6 | — | 4 | 75 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 15 | 32 | 4 | — | 1 | 45 |
| Sarcoma | D012509 | — | — | 12 | 19 | 7 | — | 4 | 37 |
| Neoplasms | D009369 | — | C80 | 19 | 20 | 1 | — | 3 | 35 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 13 | 26 | 1 | — | 3 | 34 |
| Lymphoid leukemia | D007945 | — | C91 | 12 | 24 | 4 | — | — | 34 |
| Myelodysplastic syndromes | D009190 | — | D46 | 10 | 17 | 1 | — | 2 | 25 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 10 | 15 | 1 | — | 1 | 24 |
| Myeloid leukemia | D007951 | — | C92 | 8 | 18 | 1 | — | — | 24 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 7 | 15 | 2 | — | — | 18 |
Show 38 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hematologic neoplasms | D019337 | — | — | 12 | 19 | — | — | 1 | 24 |
| Melanoma | D008545 | — | — | 9 | 15 | — | — | 1 | 22 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 11 | 12 | — | — | 1 | 18 |
| Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 2 | 12 | — | — | — | 12 |
| Syndrome | D013577 | — | — | 2 | 8 | — | — | 1 | 9 |
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 2 | 9 | — | — | — | 9 |
| Myelomonocytic leukemia juvenile | D054429 | — | C93.3 | 3 | 7 | — | — | — | 8 |
| Primary myelofibrosis | D055728 | — | D47.4 | 3 | 5 | — | — | — | 8 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 3 | 6 | — | — | — | 7 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 5 | 6 | — | — | — | 7 |
Show 137 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Wilms tumor | D009396 | EFO_0000212 | — | 2 | — | — | — | — | 2 |
| Rhabdoid tumor | D018335 | — | — | 1 | — | — | — | 1 | 2 |
| Ganglioneuroblastoma | D018305 | — | — | 1 | — | — | — | — | 1 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | 1 | — | — | — | — | 1 |
| Vasculitis | D014657 | EFO_0006803 | M31 | 1 | — | — | — | — | 1 |
| Myositis | D009220 | EFO_0000783 | G72.49 | 1 | — | — | — | — | 1 |
| Muscular diseases | D009135 | EFO_0002970 | G72.9 | 1 | — | — | — | — | 1 |
| Obesity | D009765 | EFO_0001073 | E66.9 | 1 | — | — | — | — | 1 |
| Myasthenia gravis | D009157 | EFO_0004991 | G70.0 | 1 | — | — | — | — | 1 |
| Muscle weakness | D018908 | — | — | 1 | — | — | — | — | 1 |
Show 8 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Nausea | D009325 | — | R11.0 | — | — | — | — | 2 | 2 |
| Drug-related side effects and adverse reactions | D064420 | — | T88.7 | — | — | — | — | 1 | 1 |
| Aggression | D000374 | EFO_0003015 | — | — | — | — | — | 1 | 1 |
| Histiocytosis | D015614 | HP_0100727 | — | — | — | — | — | 1 | 1 |
| Langerhans-cell histiocytosis | D006646 | — | C96.6 | — | — | — | — | 1 | 1 |
| Wiskott-aldrich syndrome | D014923 | EFO_0003903 | D82.0 | — | — | — | — | 1 | 1 |
| Severe combined immunodeficiency | D016511 | — | D81.0 | — | — | — | — | 1 | 1 |
| Hemophagocytic lymphohistiocytosis | D051359 | — | D76.1 | — | — | — | — | 1 | 1 |
| Chronic granulomatous disease | D006105 | EFO_0000338 | D71 | — | — | — | — | 1 | 1 |
| Type 1 hyper-igm immunodeficiency syndrome | D053307 | — | — | — | — | — | — | 1 | 1 |
Show 12 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
6,544 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use